Literature DB >> 24259404

Biofield therapies for symptom management in palliative and end-of-life care.

Ashley M Henneghan1, Rosa N Schnyer2.   

Abstract

Terminally ill patients experience negative symptoms at end of life (EOL) that hinder well-being and quality of life (QOL). Current intervention strategies are not always effective or feasible. A focused literature review to evaluate the use of biofield therapies (ie, Therapeutic Touch, Healing Touch, and Reiki) to manage the symptoms in EOL revealed no studies on the use these therapies, specifically in this population. Evidence from studies on relevant populations (patients with cancer, elderly patients, and patients experiencing chronic pain), which addressed the outcomes relevant to palliative and EOL care (EOLC; pain levels, changes in psychological symptoms, well-being, and QOL), supports the use of biofield therapies in relieving pain, improving QOL and well-being, and reducing psychological symptoms of stress. Further research to assess the use of biofield therapies in EOLC is clearly needed.
© The Author(s) 2013.

Entities:  

Keywords:  Therapeutic Touch; biofield therapies; complementary medicine; end-of-life care; hospice care; palliative care; symptom management

Mesh:

Year:  2013        PMID: 24259404     DOI: 10.1177/1049909113509400

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  4 in total

1.  Work environment facilitators to the availability of complementary and alternative therapies in perinatal hospices.

Authors:  Charlotte Wool; Leila E Kozak; Lisa C Lindley
Journal:  J Hosp Palliat Nurs       Date:  2015-10       Impact factor: 1.918

2.  Complementary Therapies for Symptom Management in Cancer Patients.

Authors:  Aanchal Satija; Sushma Bhatnagar
Journal:  Indian J Palliat Care       Date:  2017 Oct-Dec

3.  The Influence of a Multimodal Health Program with Diet, Art, and Biofield Therapy on the Quality of Life of People in Japan.

Authors:  Kiyoshi Suzuki; Tomoaki Kimura; Seiya Uchida; Hiroshi Katamura; Hideaki Tanaka
Journal:  J Altern Complement Med       Date:  2019-02-11       Impact factor: 2.579

4.  Clinical Studies of Biofield Therapies: Summary, Methodological Challenges, and Recommendations.

Authors:  Shamini Jain; Richard Hammerschlag; Paul Mills; Lorenzo Cohen; Richard Krieger; Cassandra Vieten; Susan Lutgendorf
Journal:  Glob Adv Health Med       Date:  2015-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.